Jubilant Biosys integrated small-molecule drug discovery services.
Integrated Drug Discovery Services is Jubilant Biosys' offering for small-molecule drug discovery programs. It is delivered under milestone and hybrid collaboration models with pharmaceutical and biotechnology clients.
The service combines discovery capabilities across biology and chemistry to advance small-molecule programs from target identification toward preclinical development.
Adds products that compete with one of Integrated Drug Discovery Services’ direct competitors but not with Integrated Drug Discovery Services itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | Integrated Drug Discovery Services | Drug Discovery Partnerships | Integrated Drug Discovery and Development | Integrated Drug Discovery and Development | |
|---|---|---|---|---|---|
| Linked Through | — | Direct competitor | Drug Discovery Partnerships | Drug Discovery Partnerships | |
| Provider |  |  |  |  | |
| Founded | 1998 | 2006 | 1947 | — | |
| Sells To | Enterprise | Businesses | Enterprise, Small Business | — | |
| Pricing Model | — | Pre-Revenue | Recurring, Transactional | — | |
| Ownership | Public | Private | Public | — |
Provider
Founded 1998
Sells To Enterprise
Pricing Model —
Ownership Public
Provider
Founded 2006
Sells To Businesses
Pricing Model Pre-Revenue
Ownership Private
Linked Through Drug Discovery Partnerships
Provider
Founded 1947
Sells To Enterprise, Small Business
Pricing Model Recurring, Transactional
Ownership Public
Linked Through Drug Discovery Partnerships
Provider
Founded —
Sells To —
Pricing Model —
Ownership —
Charles River integrated small-molecule drug discovery and development services.
Pharmaron integrated drug discovery services with milestone-based models.
Charles River integrated small-molecule drug discovery and development services.
Pharmaron integrated drug discovery services with milestone-based models.